Cooperative roles for Atm and Hus1 in genome maintenance
Cooperative roles for Atm and Hus1 in genome maintenance
批准号:
7791626
负责人:
Robert S Weiss
金额:
$1.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2011-04-30
关键词:
AddressAffectAllelesAnimal ModelAnimalsAtaxia TelangiectasiaBirthCell Culture TechniquesComplexCultured CellsDNA DamageDNA Double Strand BreakDNA damage checkpointDNA lesionDefectDevelopmentDiseaseEmbryoEmployee StrikesFibroblastsFrequenciesFutureGeneticGenomeGenomic InstabilityGenomicsHeadHumanImmune System DiseasesImpairmentIndividualInfertilityKnockout MiceLifeLightMaintenanceMalignant NeoplasmsMammalsModelingMolecularMusMutationNeoplasmsNerve DegenerationOncogenesPathogenesisPathway interactionsPatientsPhenotypePhysiologicalPlayPredispositionProtein KinaseProteinsRadiation ToleranceResearchRiskRisk AssessmentRoleSeriesSeverity of illnessSignal TransductionStressSyndromeTestingThymic LymphomaTissuesTubeTumor Suppressor Proteinsbasecancer riskclinical phenotypein vivoinsightmalignant breast neoplasmmouse modelpreventprogramsprogressive neurodegenerationresearch studyresponsesenescencetooltranslational studytumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Ataxia-Telangiectasia is a genomic instability syndrome in which mutations in the DNA damage
checkpoint protein Atm cause neurodegeneration, cancer predisposition, infertility, and immune
dysfunction. Atm plays a central role in cellular responses to double-stranded DNA breaks (DSB),
while a second pathway involving the related checkpoint protein Atr responds to replication stress and
bulky DNA lesions, as well as DSB. The extent of functional overlap between these pathways is
incompletely understood in part because components of the Atr pathway, which also includes Chk1
and the Rad9-Rad1-Hus1 (911) complex, are essential for viability. The long-term objectives of the
research described in this proposal are to resolve the relationship between the Atm and Atr pathways
and to determine how the activity of the Atr pathway affects disease pathogenesis when Atm is
defective. We employed a Hus1 allelic series in mice to identify genetic interactions between the Atm
and Atr pathways. Synthetic lethality was observed when partial Hus1 impairment was combined
with Atm deficiency, establishing an essential cooperative relationship between the two primary
mammalian DNA damage checkpoint pathways. Although a severe reduction in Hus1 expression
was lethal in combination with Atm loss, a slightly higher level of Hus1 expression yielded viable mice
at less than expected frequency. In aim one, the basis for the embryonic lethality will be determined
by morphological and histological analysis of embryos as well as by examination of DNA damage
signaling in cultured cells with both Atm and Hus1 defects. In addition, surviving mice with
simultaneous Atm and Hus1 defects will be tested for neurodegeneration, a prominent phenotype of
Ataxia-Telangiectasia patients that is not observed in Atm knockout mice. In aim two, the impact of
reduced Hus1 function on tumor development in Atm-deficient mice will be assessed. Atm
heterozygosity confers an increased risk of breast cancer in humans, and therefore tumorigenesis will
also be examined in heterozygous Atm mice with a partial Hus1 defect. Taken together, the
proposed studies will clarify the relationship between two primary mammalian DNA damage
checkpoint pathways and resolve the cooperative roles for these genome maintenance mechanisms
in executing developmental programs, preventing neurodegeneration, and suppressing
tumorigenesis. RELEVANCE
Ataxia-Telangiectasia is a devastating disease with an estimated frequency of 1 in 40,000 births. The
proposed research will determine how the severity of this disease, which can vary significantly
between individuals, is affected by the activity of a related pathway. The studies also will clarify the
organization of the signaling networks responsible for the maintenance of genomic integrity and may
produce a more accurate mouse model for Ataxia-Telangiectasia for future translational studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQD2) Molecular Basis for the Chemosensitivity of Testicular Germ Cell Cancers
-
批准号:8842115
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2014
-
负责人:Robert S Weiss
-
依托单位:
(PQD2) Molecular Basis for the Chemosensitivity of Testicular Germ Cell Cancers
-
批准号:8687336
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2014
-
负责人:Robert S Weiss
-
依托单位:
Cornell University Veterinary Investigator Program
-
批准号:10401771
-
项目类别:
-
资助金额:$6.75万
-
财政年份:2010
-
负责人:Robert S Weiss
-
依托单位:
Cornell University Veterinary Investigator Program
-
批准号:10615735
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2010
-
负责人:Robert S Weiss
-
依托单位:
Cooperative roles for Atm and Hus1 in genome maintenance
-
批准号:7617542
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2008
-
负责人:Robert S Weiss
-
依托单位:
Mark I Model 68 Gamma Irradiator
-
批准号:7221074
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2007
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:7424968
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:7876855
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:7654888
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:7233618
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:8193248
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:6809650
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:8434901
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:7110271
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
Genome maintenance by the mouse Hus1 checkpoint gene
-
批准号:6937244
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2004
-
负责人:Robert S Weiss
-
依托单位:
海外基金